Bod

A Strong Start to FY2021 Leaves Bod Well-Positioned for Continued Growth

A 339% increase in revenue on the period corresponding periods tells us Bod Australia is unfazed by a global pandemic. Bod Australia Limited (ASX: BDA) is pleased to provide this ...

Bod Australia Achieves Record Medicinal Cannabis Orders

Bod Australia Reports Achievement of Record Medicinal Cannabis Growth During Q1 FY2021.Bod Australia Limited (ASX: BDA) is pleased to report that ithas achieved record medicinal ca...

Bod Makes Progress in Achieving U.S. Market Entry

Bod's CBD and hemp oil preparation is Generally Recognised as Safe (GRAS) Adhering to Strict U.S. Regulations.Bod Australia Limited (ASX: BDA) is pleased to advise that an independ...

How Do Cannabis Company Valuations Differ Around the Globe?

Cannabis stocks have been one of the best-performing stocks globally in the last few months. While there are many names still down from their peak end of 2018, many other businesse...

Swiss Wellness and BOD Collaborate to Launch Hemp Products In Australian Stores

Swisse and BOD will soon be in 2000 Australian stores with their hemp and CBD products. In their first product collaboration together, Australian medical cannabis, CBD and hemp bra...

Bod Australia Limited Receives Tax Incentive Refund

Bod Australia Limited receives $851,000 through an R&D tax refund.Medicinal cannabis healthcare products company, Bod Australia Limited (ASX: BDA) is pleased to advise that it ...